Establishment Labs Stock Gets A Lift From Raised Revenue Outlook
BTIG Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $93
What Establishment Labs (ESTA) Said on Its Q3 Earnings Call
Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript
Establishment Labs® Reports Third Quarter 2026 Financial Results
Establishment Labs Hldgs Q3 2026 Earnings Call Transcript
Establishment Labs Hldgs FY2026 Revenue expected to be more than $274.000M vs $270.215M Est
Establishment Labs Hldgs Q3 EPS $(0.35) Misses $(0.26) Estimate, Sales $71.993M Beat $66.460M Estimate
TD Cowen Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $95
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29
TD Cowen Reiterates Buy on Establishment Labs Hldgs, Maintains $117 Price Target
Establishment Labs Extends Master Supply Agreement With NuSil Technology To December 31, 2031
Establishment Labs Holdings (ESTA) Wins Expanded FDA Clearance, Is The Stock Still A Bargain?
Establishment Labs Hldgs Reports Q2 2026 Results: Full Earnings Call Transcript
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
Establishment Labs: Procedure Economics Strengthens The Bull Case
BTIG Reiterates Buy on Establishment Labs Hldgs, Maintains $103 Price Target
Citigroup Upgrades Establishment Labs Hldgs to Buy, Maintains Price Target to $92
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.